A detailed history of Long Road Investment Counsel, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Long Road Investment Counsel, LLC holds 5,475 shares of ABBV stock, worth $968,801. This represents 0.43% of its overall portfolio holdings.

Number of Shares
5,475
Previous 5,475 -0.0%
Holding current value
$968,801
Previous $939,000 15.12%
% of portfolio
0.43%
Previous 0.41%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $897,024 - $1.09 Million
5,475 New
5,475 $1.08 Million
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $875,014 - $996,997
5,475 New
5,475 $997,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $731,405 - $846,708
5,475 New
5,475 $816,000
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $791,739 - $911,806
5,475 New
5,475 $873,000
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $33,194 - $39,808
-240 Reduced 3.39%
6,835 $1.11 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $949,535 - $1.09 Million
7,075 New
7,075 $950,000
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $156,886 - $199,454
1,140 Added 19.21%
7,075 $1.08 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $783,301 - $971,856
5,935 New
5,935 $962,000
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $752,780 - $854,518
-7,075 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $723,772 - $796,786
7,075 New
7,075 $766,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $128,783 - $173,872
1,600 Added 28.19%
7,275 $780,000
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $624,995 - $733,538
-7,275 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $2,274 - $3,043
31 Added 0.43%
7,275 $714,000
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $467,238 - $708,390
7,244 New
7,244 $552,000
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $517,604 - $647,634
-7,176 Reduced 55.98%
5,644 $500,000
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $805,766 - $968,761
-12,794 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$77.14 - $90.79 $986,929 - $1.16 Million
12,794 New
12,794 $1.03 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $80,802 - $95,607
-900 Reduced 7.44%
11,194 $1.04 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $82,809 - $110,889
-900 Reduced 6.93%
12,094 $1.15 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $1.16 Million - $1.28 Million
-12,994 Closed
0 $0
Q2 2017

Aug 09, 2017

BUY
N/A
12,994
12,994 $942,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Long Road Investment Counsel, LLC Portfolio

Follow Long Road Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Road Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Long Road Investment Counsel, LLC with notifications on news.